【原美源伯根】Cencora (COR) 2020年年度报告「NYSE」.pdf

1、2020 Summary Annual Report23AmerisourceBergen04 About AmerisourceBergen07 CEO statement18 Financial highlights20 Management team21 Board of Directors22 GAAP/Non-GAAP financial measures24 Corporate information4About AmerisourceBergenAmerisourceBergen is one of the largest global pharmaceutical sourci

2、ng and distribution services companies,helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care.With services ranging from drug distribution and niche premium logistics to reimbursement and pharmaceutical consulting se

3、rvices,AmerisourceBergen delivers innovative programs and solutions across the pharmaceutical supply channel in human and animal health.With over$185 billion in annual revenue,AmerisourceBergen is headquartered in Valley Forge,PA,and employs approximately 22,000 people around the world.AmerisourceBe

4、rgen is ranked#10 on the Fortune 500 list.We distribute a comprehensive offering of brand name and generic pharmaceuticals including specialty pharmaceutical products,over-the-counter healthcare products,home healthcare supplies and equipment and related services to a wide variety of healthcare prov

5、iders located in the United States and select global markets.Our customers include chain retail and independent pharmacies,mail order pharmacies,acute care hospitals and health systems,physician practices,medical and dialysis clinics,long-term care and other alternate site pharmacies,veterinarians,a

6、nd others.Additionally,we furnish healthcare providers and pharmaceutical manufacturers with an assortment of related high-value services,including reimbursement and pharmaceutical consulting services,niche premium logistics services,inventory management,pharmacy automation,and pharmacy management.P